Trademark Overview
On Monday, May 13, 2024, a trademark application was filed for INOGRAFT BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the INOGRAFT BIOTHERAPEUTICS trademark a serial number of 98547760. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 13, 2024. This trademark is owned by Inograft Biotherapeutics, Inc.. The INOGRAFT BIOTHERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Stem cell-derived drug therapies for pharmaceutical purposes to treat of a wide range of diseases; stem cell-derived therapeutic preparations; stem cells for therapeutic treatment of a wide range of diseases; pharmaceutical preparations as CD47 antagonists, integrin-associated proteins (IAP), and CD47 glycoproteins; monoclonal antibodies for medical purposes; monoclonal antibodies for use to suppress immune responses that lead to rejection of stem cell and organ transplants
Stem cells for research purposes; biochemicals, namely, antibodies for in vitro scientific or research use; biochemicals, namely, decoy receptors for in vitro scientific or research use
Research and development services relating to bone marrow, stem cell, and organ transplantation; research and development in the field of stem cell therapies; research and development relating to bone marrow, stem-cell, and organ transplantation; research and development relating to pharmaceutical preparations as CD47 antagonists, integrin-associated proteins (IAP), and CD47 glycoproteins; research and development services in the field of antibodies; research and development relating to using monoclonal antibodies to suppress immune responses that lead to rejection of stem cell and organ transplants